Cargando…

Bronchodilators in COPD: Impact of β-agonists and anticholinergics on severe exacerbations and mortality

This review summarizes the long-term clinical outcomes associated with β-agonist and anticholinergic bronchodilator use in patients with chronic obstructive pulmonary disease (COPD). Pooled data from randomized placebo-controlled trials of at least three months duration were used to evaluate the ris...

Descripción completa

Detalles Bibliográficos
Autor principal: Salpeter, Shelley R
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2692116/
https://www.ncbi.nlm.nih.gov/pubmed/18044061